Lexent Bio
formerly LexentBioAcquiredSan Francisco, United States · Founded 2009 · $10.2M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2009
- Business Model
- B2B
- Website
- lexentbio.com
- Total Funding
- $10.2M
- Last Round
- $10.2M Venture Round
- Rounds
- 1
About
Lexent Bio developed novel liquid biopsy technology to diagnose and treat cancer. Acquired by Foundation Medicine in June 2020.
Summary
Lexent Bio is a Biotech company based in San Francisco, United States, founded in 2009. It has raised $10.2M in total across 1 round. Investors include Charge Ventures, Correlation Ventures and iFly.vc.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Unknown
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Alphabet-backed biotechnology company researching biology of aging and developing interventions t...
BridgeBio makes targeted treatments for genetic diseases.